Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)

Market Cap	2.23B
Revenue (ttm)	607.13M
Net Income (ttm)	-281.05M
Shares Out	349.86M
EPS (ttm)	-0.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,731,020
Average Volume	6,114,599
Open	6.38
Previous Close	6.38
Day's Range	6.33 - 6.80
52-Week Range	4.63 - 7.09
Beta	0.24
RSI	62.61
Earnings Date	Aug 29, 2025

About SHE:000952

Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations in China. The company also exports its products to approximately 30 countries and regions worldwide. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1969
• Employees: 1,398
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000952

Financial Performance

In 2024, SHE:000952's revenue was 638.80 million, a decrease of -13.42% compared to the previous year's 737.82 million. Losses were -295.29 million, 110.5% more than in 2023.